MAMA Stock Analysis: Mama's Creations | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 812m USD | 12M Return: 115.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 10.4M
EPS Trend: -51.6%
Qual. Beats: 3
Rev. Trend: 97.2%
Qual. Beats: 7
Warnings
Tailwinds
Seasonality 10.5 years of data
Average return per month, with how dependable it is below — did the month move the same way every year (high) or randomly (low). Above 60 is a pattern worth trusting; under 40 is noise.
Mamas Creations, Inc. (NASDAQ: MAMA) is a U.S.-based manufacturer and marketer of fresh deli-prepared foods, with a product portfolio centered on chicken, beef, and turkey meatballs, meat loaf, sausage-related items, and pasta and rice entrees, as well as olives, hot bars, salad bars, sandwiches, and cold deli/foods-to-go offerings. The company operates a business-to-business distribution model, selling directly to supermarkets, club chains, and mass-market retailers, alongside food distributors and retailers, with supplementary sales through its website and social media channels.
Headquartered in East Rutherford, New Jersey, and incorporated in 2009, the company was previously known as MamaMancinis Holdings, Inc. before rebranding to Mamas Creations, Inc. in August 2023. It is classified within the Consumer Staples sector under the Packaged Foods & Meats sub-industry, a defensive segment of the market that tends to generate relatively stable demand given the everyday, non-discretionary nature of its products.
The fresh deli-prepared foods category in which Mamas Creations operates has historically benefited from consumer demand for convenient, ready-to-eat meal solutions at retail deli counters, a distribution channel that sits between traditional packaged grocery and foodservice.
- New retail distribution wins accelerate double-digit revenue growth
- Meat and labor input costs pressure gross margins
- Fresh prepared food demand lifts deli category sales
| Net Income: 6.11m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 4.65 > 1.0 |
| NWC/Revenue: 14.68% < 20% (prev 4.28%; Δ 10.40% < -1%) |
| CFO/TA 0.12 > 3% & CFO 10.4m > Net Income 6.11m |
| Net Debt (-2.11m) to EBITDA (14.0m): -0.15 < 3 |
| Current Ratio: 2.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.3m) vs 12m ago 10.01% < -2% |
| Gross Margin: 24.46% > 18% (prev 25.05%; Δ -0.59% > 0.5%) |
| Asset Turnover: 269.8% > 50% (prev 244.2%; Δ 25.65% > 0%) |
| Interest Coverage Ratio: 16.57 > 6 (EBIT TTM 8.30m / Interest Expense TTM 501k) |
| A: 0.32 (Total Current Assets 48.8m - Total Current Liabilities 21.0m) / Total Assets 87.5m |
| B: 0.09 (Retained Earnings 7.51m / Total Assets 87.5m) |
| C: 0.12 (EBIT TTM 8.30m / Avg Total Assets 70.1m) |
| D: 1.72 (Book Value of Equity 55.4m / Total Liabilities 32.2m) |
| Altman-Z'' = 4.96 = AAA |
| DSRI: 1.55 (Receivables 13.2m/5.80m, Revenue 189.2m/128.7m) |
| GMI: 1.02 (GM 25.05% / 24.46%) |
| AQI: 0.60 (AQ_t 0.14 / AQ_t-1 0.23) |
| SGI: 1.47 (Revenue 189.2m / 128.7m) |
| TATA: -0.05 (NI 6.11m - CFO 10.4m) / TA 87.5m) |
| Beneish M = -2.46 (Cap -4..+1) = BBB |
As of July 01, 2026, the stock is trading at USD 17.85 with a total of 2,550,141 shares traded. Over the past week, the price has changed by -5.61%, over one month by +25.26%, over three months by +16.36% and over the past year by +115.06%.
Current recommended Stop Loss: 16.60 (which is 7% or 1.3 ATR below the current price).
Mama's Creations has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy MAMA.
- StrongBuy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 22 | 23.2% |
P/E Trailing = 132.9333
P/E Forward = 76.9231
P/S = 4.2896
P/B = 14.6615
Revenue TTM = 189.2m USD
EBIT TTM = 8.30m USD
EBITDA TTM = 14.0m USD
Long Term Debt = 4.12m USD (from longTermDebt, last quarter)
Short Term Debt = 3.04m USD (from shortTermDebt, last quarter)
Debt = 22.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 8.61m
Net Debt = -2.11m USD (calculated: Debt 22.3m - CCE 24.4m)
Enterprise Value = 809.6m USD (811.7m + Debt 22.3m - CCE 24.4m)
Interest Coverage Ratio = 16.57 (Ebit TTM 8.30m / Interest Expense TTM 501k)
EV/FCF = 88.63x (Enterprise Value 809.6m / FCF TTM 9.13m)
FCF Yield = 1.13% (FCF TTM 9.13m / Enterprise Value 809.6m)
FCF Margin = 4.83% (FCF TTM 9.13m / Revenue TTM 189.2m)
Net Margin = 3.23% (Net Income TTM 6.11m / Revenue TTM 189.2m)
Gross Margin = 24.46% ((Revenue TTM 189.2m - Cost of Revenue TTM 142.9m) / Revenue TTM)
Gross Margin QoQ = 23.55% (prev 25.85%)
Tobins Q-Ratio = 9.25 (Enterprise Value 809.6m / Total Assets 87.5m)
Interest Expense / Debt = 2.25% (Interest Expense 501k / Debt 22.3m)
Taxrate = 23.37% (1.86m / 7.97m)
NOPAT = 6.36m (EBIT 8.30m * (1 - 23.37%))
Current Ratio = 2.32 (Total Current Assets 48.8m / Total Current Liabilities 21.0m)
Debt / Equity = 0.40 (Debt 22.3m / totalStockholderEquity, last quarter 55.4m)
Debt / EBITDA = -0.15 (Net Debt -2.11m / EBITDA 14.0m)
Debt / FCF = -0.23 (Net Debt -2.11m / FCF TTM 9.13m)
Total Stockholder Equity = 46.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.71% (Net Income 6.11m / Total Assets 87.5m)
RoE = 13.05% (Net Income TTM 6.11m / Total Stockholder Equity 46.8m)
RoCE = 16.30% (EBIT 8.30m / Capital Employed (Equity 46.8m + L.T.Debt 4.12m))
RoIC = 10.58% (NOPAT 6.36m / Invested Capital 60.1m)
WACC = 8.89% (E(811.7m)/V(834.0m) * Re(9.09%) + D(22.3m)/V(834.0m) * Rd(2.25%) * (1-Tc(0.23)))
Discount Rate = 9.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 73.33 | Cagr: 7.22%
[DCF] Terminal Value 76.23% ; FCFF base≈6.70m ; Y1≈7.68m ; Y5≈11.3m
[DCF] Fair Price = 3.87 (EV 155.3m - Net Debt -2.11m = Equity 157.4m / Shares 40.7m; r=8.89% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -51.61 | EPS CAGR: -12.90% | SUE: 1.14 | # QB: 3
Revenue Correlation: 97.15 | Revenue CAGR: 25.94% | SUE: 0.89 | # QB: 7
EPS current Quarter (2026-07-31): EPS=0.00 | Chg30d=N/A | Revisions=-20% | Analysts=0
EPS next Quarter (2026-10-31): EPS=0.07 | Chg30d=+13.79% | Revisions=+0% | Analysts=5
EPS current Year (2027-01-31): EPS=0.27 | Chg30d=+17.24% | Revisions=-43% | GrowthEPS=+109.2% | GrowthRev=+30.1%
EPS next Year (2028-01-31): EPS=0.40 | Chg30d=+7.03% | Revisions=-20% | GrowthEPS=+45.6% | GrowthRev=+12.2%
[Analyst] Revisions Ratio: -43%